13 Matching Annotations
  1. Last 7 days
    1. Mutations in LRP5 or FZD4 Underlie the Common Familial Exudative Vitreoretinopathy Locus on Chromosome 11q

      PMID: 15024691

      Gene: LRP5

      HGNC: 6697

      Disease: osteoporosis-pseudoglioma syndrome

      MONDO: 0009820

      InheritancePattern: autosomal recessive

      Prevalence: osteoporosis-pseudoglioma syndrome is estimated to occur in 1 out of every 2,000,000 live births.

      Penetrance: The penetrance of the phenotype among homozygous or compound heterozygous cases appears to be complete, while heterozygous carriers of deleterious variants appear to be mildly affected.

    1. Osteoporosis-pseudoglioma syndrome: Description of 9 new cases and beneficial response to bisphosphonates

      PMID: 18602879

      Gene: LRP5

      HGNC: 6697

      Disease: osteoporosis-pseudoglioma syndrome

      MONDO: 0009820

      InheritancePattern: autosomal recessive

      Prevalence: osteoporosis-pseudoglioma syndrome is estimated to occur in 1 out of every 2,000,000 live births.

      Penetrance: The penetrance of the phenotype among homozygous or compound heterozygous cases appears to be complete, while heterozygous carriers of deleterious variants appear to be mildly affected.

    1. Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG)

      PMID: 21407258

      Gene: LRP5

      HGNC: 6697

      Disease: osteoporosis-pseudoglioma syndrome

      MONDO: 0009820

      InheritancePattern: autosomal recessive

      Prevalence: osteoporosis-pseudoglioma syndrome is estimated to occur in 1 out of every 2,000,000 live births.

      Penetrance: The penetrance of the phenotype among homozygous or compound heterozygous cases appears to be complete, while heterozygous carriers of deleterious variants appear to be mildly affected.

    1. E1270fs

      Case#: Gong_2001_Proband_6, no reported gender, age or national origin

      CasePresentingHPOs: HP:0004349 (Reduced bone mineral density)

      CaseHPOFreeText: The proband has been diagnosed with osteoporosis-pseudoglioma syndrome segregating with an autosomal recessive mode of inheritance. This implies a combination of ophthalmologic and radiographic features, but these have not been described in detail.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: Genome-wide linkage mapping with 160 SSRP markers was performed on three different consanguineous kindreds (from Finland, South Africa, and Italy) (fig. 1), but it is not clear whether this proband was a member of one of these kindreds.

      CaseMethod1: Linkage analysis with additional markers around a strong candidate marker

      CaseMethod2: Sanger sequencing of PCR-amplified exons and flanking regions of the LRP5 locus

      CaseGenotypingMethod: Genotyping appears to have been limited to Sanger sequencing of PCR-amplified exons and flanking regions of the LRP5 locus.

      Variant: The patient harbors the NM_002335.4(LRP5):c.3804del (p.Glu1270fs) variant in the homozygous state.

      ClinVar: 6273

      gnomAD: The NM_002335.4(LRP5):c.3804del (p.Glu1270fs) variant was not found in gnomAD v2.1.1.

      VariantEvidence: NM_002335.4(LRP5):c.3804del (p.Glu1270fs) is a frameshift variant in exon 18 out of 23 that is predicted to trigger nonsense-mediated decay or at least to truncate the C-terminal ~21% of the protein product. It appears to be stable at the protein level but is not secreted in the exogenous expression system, consistent with loss-of-function rather than dominant negative effect.

      CaseAddInfo: The family is reportedly consanguineous.

      CasePMIDs: PMID: 8659519

    2. homozygous frameshift

      Case#: Gong_2001_Proband_1, no reported gender, age or national origin

      CasePresentingHPOs: HP:0004349 (Reduced bone mineral density)

      CaseHPOFreeText: The proband has been diagnosed with osteoporosis-pseudoglioma syndrome segregating with an autosomal recessive mode of inheritance. This implies a combination of ophthalmologic and radiographic features, but these have not been described in detail.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: Genome-wide linkage mapping with 160 SSRP markers was performed on three different consanguineous kindreds (from Finland, South Africa, and Italy) (fig. 1), but it is not clear whether this proband was a member of one of these kindreds.

      CaseMethod1: Linkage analysis with additional markers around a strong candidate marker

      CaseMethod2: Sanger sequencing of PCR-amplified exons and flanking regions of the LRP5 locus

      CaseGenotypingMethod: Genotyping appears to have been limited to Sanger sequencing of PCR-amplified exons and flanking regions of the LRP5 locus.

      Variant: The patient harbors the NM_002335.4(LRP5):c.29G>A (p.Trp10Ter) variant in the homozygous state.

      ClinVar: 6268

      gnomAD: The NM_002335.4(LRP5):c.29G>A (p.Trp10Ter) variant was not found in gnomAD v2.1.1.

      VariantEvidence: NM_002335.4(LRP5):c.29G>A (p.Trp10Ter) is a nonsense variant in exon 1 out of 23 that is predicted to trigger nonsense-mediated decay or at least to truncate the C-terminal ~99% of the protein product.

      CaseAddInfo: The family is reportedly consanguineous.

      CasePMIDs: PMID: 8659519

    3. While pluripotent mesenchymal cell lines can be induced into the osteoblastic lineage, they may not reflect endogenous osteoblastic proliferation and differentiation. Consequently, we sought to determine whether the secreted form of LRP5 (LRP5ΔTM) could interfere with bone accrual in calvarial explant cultures. In three independent experiments, explants that were cultured in the presence of conditioned media from cells expressing LRP5ΔTM consistently had thinner bone, as determined by ALP staining and von Kossa staining, than did explants that were cultured in conditioned media from cells expressing wild-type LRP5 (Figure 7). Thus, LRP5ΔTM is able to inhibit bone growth, presumably by binding and interfering with secreted growth factors such as Wnts.

      ExperimentName: LRP5 inhibition using a dominant negative construct blocks bone accrual in mouse calvarial explant culture.

      NonPatientCell: CL:0001035 (bone cell, specifically mouse calvarial explant cultures)

      GeneFunction: GO:0098868 (bone growth)

      GeneAlteration: Calvarial explant cultures from mice were treated with conditioned media from cells exogenously secreting either wild-type LRP5 or dominant negative LRP5deltaTM.

      FunctionalEvidence: Bone accrual / thickness decreases significantly at multiple points in mouse calvarial (skull) explants treated with LRP5deltaTM relative to LRP5-WT (Figure 7).

      FAVariants: LRP5 function was attenuated using an artificial dominant negative mutant while a human variant was not introduced into the LRP5 gene.

    4. LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development

      PMID: 11719191

      Gene: LRP5

      HGNC: 6697

      Disease: osteoporosis-pseudoglioma syndrome

      MONDO: 0009820

      InheritancePattern: autosomal recessive

      Prevalence: osteoporosis-pseudoglioma syndrome is estimated to occur in 1 out of every 2,000,000 live births.

      Penetrance: The penetrance of the phenotype among homozygous or compound heterozygous cases appears to be complete, while heterozygous carriers of deleterious variants appear to be mildly affected.

    1. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

      PMID: 11956231

      Gene: LRP5

      HGNC: 6697

      Disease: osteoporosis-pseudoglioma syndrome

      MONDO: 0009820

      InheritancePattern: autosomal recessive

      Prevalence: osteoporosis-pseudoglioma syndrome is estimated to occur in 1 out of every 2,000,000 live births.

      Penetrance: The penetrance of the phenotype among homozygous or compound heterozygous cases appears to be complete, while heterozygous carriers of deleterious variants appear to be mildly affected.

    1. c.C1870T (p.R624W)

      Case#: Zhang_2016_Pedigree_C_Proband_C001, male, 32 years old at time of report, national origin reported to be Indian.

      CasePresentingHPOs: HP:0007770 (Hypoplasia of the retina), HP:0007685 (Peripheral retinal avascularization), HP:0030666 (Retinal neovascularization)

      CaseHPOFreeText: The proband has been diagnosed with familial exudative vitreoretinopathy (FEVR).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: Premature birth, maternal drug intake during pregnancy, or other ocular disease associated with osteopenia / osteoporosis

      CasePreviousTesting: Whole exome sequencing was performed, ruling out variations in the NDP, FZD4, TSPAN12, and ZNF408 loci.

      CaseMethod1: Whole exome sequencing

      CaseMethod2: Sanger sequencing of PCR-amplified exons and flanking regions of the LRP5 locus

      CaseGenotypingMethod: Whole exome sequencing was performed, ruling out variations in the NDP, FZD4, TSPAN12, and ZNF408 loci. This was followed by Sanger sequencing of PCR-amplified exons and flanking regions of the LRP5 locus.

      Variant: The patient harbors the NM_002335.4(LRP5):c.1870C>T (p.Arg624Trp) variant in the homozygous state.

      ClinVar: 1477058

      gnomAD: The NM_002335.4(LRP5):c.1870C>T (p.Arg624Trp) variant was found in gnomAD v2.1.1 at a maximum allele frequency of 0.000008796 (1/113688) in the European non-Finnish population https://gnomad.broadinstitute.org/variant/11-68174060-C-T

      VariantEvidence: NM_002335.4(LRP5):c.1870C>T (p.Arg624Trp) is a missense variant in exon 9 out of 23 that has evidence of a functional impact on the protein product. The variant was expressed in STF cells harboring a luciferase reporter construct, showing a reduced (hypomorphic) ability to induce luciferase reporter activity compared with wild-type control LRP5. (Figure 3).

      CaseAddInfo: The proband shares the homozygous genotype with his affected mother, although the father's genotype is not available. The asymptomatic uncle and aunt are heterozygous.

      CasePMIDs: N/A

    1. Two-point linkage analyses were performed using the FASTLINK implementation of the MLINK program of the LINKAGE program package (Lathrop and Lalouel 1984; Cottingham et al. 1993). For screening, equal allele frequencies were used for all markers. For fine mapping on chromosome 11, the allele frequencies were calculated using 15 control individuals (30 chromosomes) of European ancestry.Evidence of significant linkage in the genomewidescan was first observed with markers D11S987 and D11S4191, which gave maximum LOD scores of 3.3 at θ=0 and 2.43 at θ=0, respectively. For fine mapping using markers taken from the Genethon database, additional individuals were added to the families, estimated allele frequencies were used, and the maximum LOD score for D11S987 increased to 3.6 at θ=0, whereas, for D11S4191, the LOD score decreased to −1.1 at θ=0, with a LOD score of 1.1 at θ=0.1 (table 1). By use of LOD scores ⩽−2 to exclude linkage in these families, arFEVR mapped to a 21.7-cM (311-Mb) interval flanked by D11S905 and D11S1314.

      FamilyLabel: Jiao_2004_Three_Families

      Family#PresentingHPOs: N/A

      FamilyPresentingHPOFreeText: The affected family members have been diagnosed with familial exudative vitreoretinopathy segregating with an autosomal recessive mode of inheritance.

      FamilyNotHPOs: N/A

      FamilyNotHPOFreeText: Although bone density measurements are not available, at least two of the affected individuals lack bone fractures in the first three decades of life, distinguishing their phenotype from osteoporosis-pseudoglioma syndrome.

      CountryOrigin: The three families are reportedly of European descent.

      Ethnicity: Not specifically described

      Race: The three families are reportedly of European descent.

      Family#PreviousTesting: Candidate-locus-directed linkage analysis focused on chromosome 11q, with maximum LOD score of 3.6 associated with the D11S987 microsatellite marker linked to a 311-Mb region.

      Family#Method1: Genome-wide linkage analysis

      Family#Method2: Sanger sequencing of the candidate gene LRP5

      Family#GenotypingMethod: Candidate-locus-directed linkage analysis was initially performed on all three families, focused on chromosome 11q, with maximum LOD score of 3.6 associated with the D11S987 microsatellite marker linked to a 311-Mb region. Sanger sequencing of the candidate gene LRP5 locus was subsequently performed.

      Affected: 6 genotyped

      Unaffected: 0 genotyped (although 6 unaffected individuals are genotyped but ineligible because they are from previous generations that lack affected members.

      Segregations: 3 segregations are shown by the three pedigrees in Figure 1.

      PublishedLOD: 3.6

      eLOD: N/A

      AddSegregationInfo: While none of the families would individually be eligible for inclusion in segregation evidence using an estimated LOD score, the published LOD score is sufficient for their inclusion.

      ProbandLabel: Jiao_2004_Family_68001_Proband, Jiao_2004_Family_68002_Proband, Jiao_2004_Family_68003_Proband

      Variant: The affected family members harbor one of the following three variants in homozygous state; NM_002335.4(LRP5):c.2254C>G (p.Arg752Gly), NM_002335.4(LRP5):c.4099G>A (p.Glu1367Lys), or NM_002335.4(LRP5):c.1709G>A (p.Arg570Gln)

      ClinVar: 6290, 6291, 6289

      gnomAD: NM_002335.4(LRP5):c.2254C>G (p.Arg752Gly) was not found in gnomAD v2.1.1. NM_002335.4(LRP5):c.4099G>A (p.Glu1367Lys) is present in gnomAD v2.1.1. at a frequency of 0.00001760 (2/113626) in the European non-Finnish population https://gnomad.broadinstitute.org/variant/11-68204455-G-A?dataset=gnomad_r2_1 NM_002335.4(LRP5):c.1709G>A (p.Arg570Gln) was not found in gnomAD v2.1.1.

      VariantEvidence: NM_002335.4(LRP5):c.2254C>G (p.Arg752Gly) is a missense variant in exon 10 of 23 that does not have experimental evidence of impact on the protein product. NM_002335.4(LRP5):c.4099G>A (p.Glu1367Lys) is a missense variant in exon 19 of 23 that does not have experimental evidence of impact on the protein product. NM_002335.4(LRP5):c.1709G>A (p.Arg570Gln) is a missense variant in exon 8 of 23 that does not have experimental evidence of impact on the protein product.

      FamilyAddInfo: All three families are reportedly consanguineous.

      FamilyPMIDs: N/A

    1. Whole Exome Sequencing Reveals Potentially Pathogenic Variants in a Small Subset of Premenopausal Women with Idiopathic Osteoporosis

      PMID:34743040

      Gene: LRP5

      HGNC: 6697

      Disease: osteoporosis-pseudoglioma syndrome

      MONDO: 0009820

      InheritancePattern: autosomal recessive

      Prevalence: osteoporosis-pseudoglioma syndrome is estimated to occur in 1 out of every 2,000,000 live births.

      Penetrance: The penetrance of the phenotype among homozygous or compound heterozygous cases appears to be complete, while heterozygous carriers of deleterious variants appear to be mildly affected.

    1. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes

      PMID: 15981244

      Gene: LRP5

      HGNC: 6697

      Disease: osteoporosis-pseudoglioma syndrome

      MONDO: 0009820

      InheritancePattern: autosomal recessive

      Prevalence: osteoporosis-pseudoglioma syndrome is estimated to occur in 1 out of every 2,000,000 live births.

      Penetrance: The penetrance of the phenotype among homozygous or compound heterozygous cases appears to be complete, while heterozygous carriers of deleterious variants appear to be mildly affected.